microdose of semaglutide Ozempic 'microdosing' is becoming popular. Is it safe? Microdosing Semaglutide: Does It Work

MCAS symptoms can be wide-ranging and affect multiple body systems simultaneously, including severe allergic-type reactions, chronic pain, gastrointestinal symptoms, cardiovascular symptoms such as palpitations and blood pressure changes, neurological symptoms, and fatigue

GLP-1 medications already reduce food intake by 2540% in early trials

Reduction of metabolic syndrome: Researchers are exploring its role in creating a substantial relief and improvement of broader metabolic parameters (such as metabolic rate), including nutrient metabolism, lipid profiles, insulin resistance, glucose homeostasis, appetite control, and visceral adiposity

For this reason, most patients transition to a lower, ongoing maintenance dose after the initial 23 month intensive phase, rather than stopping treatment altogether